Vitamin D receptor expression in mature osteoclasts reduces bone loss due to low dietary calcium intake in male mice
暂无分享,去创建一个
G. Atkins | P. Anderson | Y. Starczak | R. Davey | P. K. Russell | Kate R. Barratt | D. Reinke | M. Clarke
[1] R. Rizza,et al. Identification of osteoclast-osteoblast coupling factors in humans reveals links between bone and energy metabolism , 2020, Nature Communications.
[2] G. Carmeliet,et al. Vdr expression in osteoclast precursors is not critical in bone homeostasis , 2019, The Journal of Steroid Biochemistry and Molecular Biology.
[3] H. Morris,et al. Evidence for altered osteoclastogenesis in splenocyte cultures from VDR knockout mice , 2018, The Journal of Steroid Biochemistry and Molecular Biology.
[4] H. Morris,et al. Absence of vitamin D receptor in mature osteoclasts results in altered osteoclastic activity and bone loss , 2017, The Journal of Steroid Biochemistry and Molecular Biology.
[5] Takashi Nakamura,et al. VDR in Osteoblast‐Lineage Cells Primarily Mediates Vitamin D Treatment‐Induced Increase in Bone Mass by Suppressing Bone Resorption , 2017, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[6] H. DeLuca,et al. Identification of the Vitamin D Receptor in Osteoblasts and Chondrocytes But Not Osteoclasts in Mouse Bone , 2014, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[7] P. Chambon,et al. Vitamin D receptor in osteoblasts is a negative regulator of bone mass control. , 2013, Endocrinology.
[8] Luc Duong,et al. The osteoclast, bone remodelling and treatment of metabolic bone disease , 2012, European journal of clinical investigation.
[9] A. Turner,et al. Vitamin D metabolism within bone cells: Effects on bone structure and strength , 2011, Molecular and Cellular Endocrinology.
[10] T. Chambers,et al. How are osteoclasts induced to resorb bone? , 2011, Annals of the New York Academy of Sciences.
[11] Lynda F. Bonewald,et al. Sclerostin Stimulates Osteocyte Support of Osteoclast Activity by a RANKL-Dependent Pathway , 2011, PloS one.
[12] N. Athanasou. The osteoclast—what’s new? , 2011, Skeletal Radiology.
[13] R. Faccio,et al. Osteoclast motility: Putting the brakes on bone resorption , 2011, Ageing Research Reviews.
[14] H. Morris,et al. Osteoclastic metabolism of 25(OH)-vitamin D3: a potential mechanism for optimization of bone resorption. , 2010, Endocrinology.
[15] H. Morris,et al. The metabolism of 25-(OH)vitamin D3 by osteoclasts and their precursors regulates the differentiation of osteoclasts , 2010, The Journal of Steroid Biochemistry and Molecular Biology.
[16] A. Turner,et al. Bone CYP27B1 gene expression is increased with high dietary calcium and in mineralising osteoblasts , 2010, The Journal of Steroid Biochemistry and Molecular Biology.
[17] V. Everts,et al. Osteoclast heterogeneity: lessons from osteopetrosis and inflammatory conditions. , 2009, Biochimica et biophysica acta.
[18] Tiina Laitala-Leinonen,et al. Osteoclast lineage and function. , 2008, Archives of biochemistry and biophysics.
[19] H. E. Maclean,et al. Current and future approaches using genetically modified mice in endocrine research. , 2006, American journal of physiology. Endocrinology and metabolism.
[20] A. Cassady,et al. Transgenic mice that express Cre recombinase in osteoclasts , 2004, Genesis.
[21] A. Evdokiou,et al. RANKL Expression Is Related to the Differentiation State of Human Osteoblasts , 2003, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[22] L. Bonewald,et al. MLO‐Y4 Osteocyte‐Like Cells Support Osteoclast Formation and Activation , 2002, Journal of bone and mineral research : the official journal of the American Society for Bone and Mineral Research.
[23] S. Geary,et al. Osteoprotegerin inhibits osteoclast formation and bone resorbing activity in giant cell tumors of bone. , 2001, Bone.
[24] S. Geary,et al. Bidirectional signaling between stromal and hemopoietic cells regulates interleukin-1 expression during human osteoclast formation. , 1999, Bone.
[25] R. Baron,et al. Targeted ablation of the vitamin D receptor: an animal model of vitamin D-dependent rickets type II with alopecia. , 1997, Proceedings of the National Academy of Sciences of the United States of America.
[26] M. Haussler,et al. Molecular Mechanisms of Vitamin D Action , 2012, Calcified Tissue International.